2018
DOI: 10.1016/j.msard.2018.02.016
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of multiple sclerosis in Poland

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
28
1
4

Year Published

2018
2018
2021
2021

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 37 publications
(35 citation statements)
references
References 20 publications
6
28
1
4
Order By: Relevance
“…This study is the first one to have enrolled all RRMS patients treated with DMTs reimbursed by the NFZ in Poland. The mean age of participants and the sex ratio are similar to previously reported observations from Poland and other countries [1][2][3][4][5][6][7][8][9][10]. Interestingly, we found that a significantly higher percentage of men was treated in the second-line programme than in the first-line.…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…This study is the first one to have enrolled all RRMS patients treated with DMTs reimbursed by the NFZ in Poland. The mean age of participants and the sex ratio are similar to previously reported observations from Poland and other countries [1][2][3][4][5][6][7][8][9][10]. Interestingly, we found that a significantly higher percentage of men was treated in the second-line programme than in the first-line.…”
Section: Discussionsupporting
confidence: 89%
“…The estimated number of people suffering from MS worldwide is approximately 2.3 million [1,2]. In Poland, there are around 45,000 patients, with a prevalence of approximately 110-115/100,000 residents [3,4].…”
Section: Introductionmentioning
confidence: 99%
“…23 A recent study has shown that Poland is a high-risk area for MS, with the overall crude prevalence rate of confirmed MS patients approximately 110/100 000 inhabitants. 24 As the current population of Poland is almost 38.5 million people, this prevalence of MS equates to approximately 42 000 patients. In SCI, it has been estimated that approximately 81% of SCI patients will undergo some degree of urinary dysfunction within 1 year, and <1% of these patients will make a full recovery.…”
Section: Discussionmentioning
confidence: 99%
“…Poland is considered to be a high-risk area for MS, with a crude prevalence rate of 108.7/100,000 for the Podlaskie Voivodeship (similar in other regions of Poland) [5]. The MS patient group chosen for the study was statistically representative of the population of patients with relapsing-remitting MS in the Podlaskie Voivodeship.…”
Section: Discussionmentioning
confidence: 99%